期刊文献+

直肠癌浸润前沿CD97与其配体CD55的表达及预后影响 被引量:2

Expression of CD97 and CD55 at the invasion front of rectal carcinomas and its association with the disease prognosis
下载PDF
导出
摘要 目的 探讨直肠癌浸润前沿区域CD97和配体CD55的表达与肿瘤复发转移及预后的关系.方法 用免疫组化方法检测71例直肠癌组织及30例正常结直肠组织CD97和CD55的表达情况.结果 直肠癌组织CD97、CD55表达水平显著高于正常肠黏膜组织,浸润前沿区域癌细胞CD97高表达患者肿瘤复发和/或转移率(67.8%)显著高于低表达患者(30.0%),浸润前沿区域间质CD55高表达患者复发和/或转移率(64.5%)显著高于低表达患者(32.5%)(均P〈0.05).浸润前沿区域癌细胞CD97表达与间质CD55表达呈正相关(r=0.392,P〈0.05).单因素分析显示淋巴结转移、TNM Ⅱ~Ⅳ期、浸润前沿癌细胞CD97高表达为影响术后生存率的危险因素(均P〈0.05).多因素分析显示淋巴结转移及浸润前沿癌细胞CD97高表达是影响直肠癌预后的独立危险因素(均P〈0.05).结论 直肠癌浸润前沿区域CD97及其配体CD55表达水平与肿瘤复发转移以及预后密切相关. Objective To investigate the expression of CD97 and its ligand CD55 at the invasion front of rectal carcinoma and its association with the disease prognosis. Methods The expression of CD97 and CD55 was immunohistologically detected in 71 tissue specimens of rectal carcinomas and 30 specimens of normal rectal tissue. Results The expression of CD97 and CD55 in rectal tumor tissues were significantly higher than that in normal rectal tissues (both, P〈0.05). And the recurrence and/or metastasis rate (67.8%) in patients with high CD97 expression at the invasion front was significantly higher than that (30.0%) in patients with lower expression (P〈0.05). The recurrence and/or metastasis rate (64.5%) in patients with high CD55 expression at the invasion front was higher than that (32.5%) in patients with lower CD55 expression (P〈0.05). The expression of CD97 at tumor cells of invasion front was correlated with that of CD55 in the stroma at invasion front (r=0.392, P〈0.05). Univariate analysis indicated that lymph node metastasis, stage Ⅱ~Ⅳ and high CD97 expression at the invasion front were risk factors for postopera- tive survival rate (P〈0.05); multivariate analysis showed that only lymph node metastasis and high CD97 expression at the inva- sion front had statistical significance (P〈0.05). Conclusion The expressions of CD97 and its ligand CD55 at the invasion front of rectal carcinoma are related to the recurrence, metastasis, and poor prognosis of rectal carcinomas.
出处 《浙江医学》 CAS 2010年第9期1311-1314,1317,共5页 Zhejiang Medical Journal
关键词 直肠肿瘤 浸润前沿 CD97 CD55 预后 Rectal carcinomas Invasion front CD97 CD55 Prognosis
  • 相关文献

参考文献13

  • 1Bryne M,Boysen M,Alfsen C G,et al.The invasive front of carcinomas.The most important area for tumor prognosis[J]? Anticancer Res,1998,18:4757-4764.
  • 2Christofor G.New signals from the invasive front[J].Nature,2006,441:444-450.
  • 3Wever D,Pauwels P,Craene D,et al.Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front[J].Histochem Cell Biol,2008,130:481-494.
  • 4Meknight A J,Gordon S.The EGF-TM7 family:unusual structures at the leukocyte surface[J].J Leukoc Biol,1998,63:271-280.
  • 5Galle J,Sittiq D,Hanisch I,et al.Individual cell based models of tumor environment interactions:Multiple effects of CD97 on tumor invasion[J].Am J Pathol,2006,169:1802-1811.
  • 6Wang T,Ward Y,Tian L,et al.CD97,an adhesion receptor on inflammatory cells,stimulates angiogenesis through binding integrin counter receptors on endothelial cells[J].Blood,2005,105(7):2836-2844.
  • 7Steinert M,Wobus M,Boltze C,et al.Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues[J].Am J Pathol,2002,161:1657-1667.
  • 8Mikesch J H,Schier K,Roetger A,et al.The expression and action of decay-accelerating factor(CD55)in human malignancies and cancer therapy[J].Cell Oncol,2006,28:223-232.
  • 9Xu J X,Moriia E,Liu Y,et al.High tolerance to apoptotic stimuli induced by serum depletion and ceramide in side-population cells:High expression of CD55 as a novel character for side-population[J].Exp Cell Res,2007,313(9):1877-1885.
  • 10Mustafa T,Klonisch T,Hombach K S,et al.Expression of CD97 and CD55 in human medullary thyroid carcinomas[J].Int J Oncol,2004,24:285-294.

同被引文献32

  • 1王芹,张玲,张维东,魏丽,贾青.胃癌组织衰变加速因子表达及其临床意义的研究[J].中华肿瘤防治杂志,2008,15(9):683-686. 被引量:8
  • 2Dunn GP,Old LJ,Schreiber RD. The immunobiology of cancer immunosurveillanee and immunoediting[J].Immunity,2004,(02):137-148.doi:10.1016/j.immuni.2004.07.017.
  • 3Fishelson Z,Donin N,Zell S. Obstacles to cancer immunotherapy:expression of membrane complement regulatory proteins (mCRPs) in tumors[J].Molecular Immunology,2003,(2/4):109-123.
  • 4De Nardo C,Fonsatti E,Sigalotti L. Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells[J].Journal of Cellular Physiology,2002,(02):200-206.
  • 5Lukacik P,Roversi P,White J. Complement regulation at the molecular level:the structure of decay-accelerating factor[J].Proceedings of the National Academy of Sciences(USA),2004,(05):1279-1284.
  • 6Ravindranath NM,Shuler C. Cell-surface density of complement restriction factors (CD46,CD55,and CD59):oral squamous cell carcinoma versus other solid rumors[J].Oral Stag Oral Med Oral Pathol Oral Radiol Ended,2007,(02):231-239.
  • 7Tae-Hwa Baek,Joo-Heon Kim,Mee-Ja Park. The stromal overexpression of decay accelerating factor (DAF/CD55) correlates with poor clinical outcome in colorectal cancer patients[J].Korean Journal of Plant Pathology,2011,(05):445-454.
  • 8Mustafa T,Klonisch T,Hombach-Klonisch S. Expression of CD97 and CD55 in human medullary thyroid carcinomas[J].International Journal of Oncology,2004,(02):285-294.
  • 9Loberg RD,Day LL,Dunn R. Inhibition of decayaccelerating factor (CD55) attenuates prostate cancer growth and survival in vivo[J].Neoplasia,2006,(01):69-78.
  • 10Bj(o)rge L,Stoiber H,Dierieh MP. Minimal residual disease in ovarian cancer as a targe:for complement-mediated mAb immunotherapy[J].Scandinavian Journal of Immunology,2006,(05):355-364.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部